LataMed AI is trading at $0.99, down 76.75% today after a 5-for-1 forward stock split and mandatory share exchange became effective for July trading.

  • The significant per-share price reduction is a mechanical result of the split and exchange, though the stock is currently trading under a temporary ticker and new CUSIP.
  • The transition has triggered elevated volatility and penny-stock optics as investors reassess the impact of dilution and the company's future capital-raising plans.